Sitagliptin Mylan 50 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin mylan 50 mg

viatris limited, Írsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin Sandoz 100 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin sandoz 100 mg

sandoz gmbh, rakúsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin Sandoz 50 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin sandoz 50 mg

sandoz gmbh, rakúsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Jalra Európska únia - slovenčina - EMA (European Medicines Agency)

jalra

novartis europharm limited - vildagliptín - diabetes mellitus, typ 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pre dostupné údaje o rôznych kombináciách).

Xiliarx Európska únia - slovenčina - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - vildagliptín - diabetes mellitus, typ 2 - lieky používané pri cukrovke - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pre dostupné údaje o rôznych kombináciách).

Galvus Európska únia - slovenčina - EMA (European Medicines Agency)

galvus

novartis europharm limited - vildagliptín - diabetes mellitus, typ 2 - lieky používané pri cukrovke - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Vildagliptin Sandoz 50 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

vildagliptin sandoz 50 mg

sandoz pharmaceuticals d.d., slovinsko - vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin STADA 100 mg filmom obalené tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin stada 100 mg filmom obalené tablety

stada arzneimittel ag, nemecko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin Grindeks 100 mg filmom obalené tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin grindeks 100 mg filmom obalené tablety

as grindeks, lotyšsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)

Sitagliptin Grindeks 25 mg filmom obalené tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sitagliptin grindeks 25 mg filmom obalené tablety

as grindeks, lotyšsko - sitagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)